|
|
|
13.01.26 - 23:36
|
Blue Matter ergänzt neue Fähigkeiten in der biopharmazeutischen Forschung und Entwicklung unter der Führung von Partnerin Tara Austraat-Churik (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Blue Matter hat einen neuen Praxisbereich gegründet, der auf die Bedürfnisse von Kunden aus der biopharmazeutischen Forschung und Entwicklung (FuE) ausgerichtet ist. Geleitet wird der Praxisbereich von Tara Austraat-Churik, einer Partnerin, die seit September 2025 für Blue Matter tätig ist.
Tara Austraat-Churik ist bereits seit über 20 Jahren für Life-Science-Kunden tätig. Ihre Schwerpunkte sind Strategieentwicklung und -umsetzung, Betriebsmodell- und Organisationsgestaltung sowie Prozessoptimierung in den Bereichen Forschung und Entwicklung sowie Medical Affairs. Bevor sie zu Blue Matter wechselte, war sie als Managing Director im Bereich Forschung und Entwicklung, Gesundheit, Wissenschaft und Wellness bei EY tätig. Sie bringt umfangreiche Erfahrungen im Consulting-Bereich mit, die sie unter anderem bei Booz Allen Hamilton, Navitas, WPP und IBM sammeln konnte. Sie hat einen BA- und MA-Abschluss der University of Notre Dame und einen MSc-Abschluss in translationaler Medi...
|
|
|
13.01.26 - 23:06
|
Meta Shifts to AI Devices From Metaverse | Bloomberg Tech 1/13/2026 (Bloomberg)
|
|
|
Bloomberg's Caroline Hyde and Ed Ludlow discuss Meta's plans to double the output of its Ray-Ban AI-glasses as it pivots away from the metaverse. Plus, Microsoft pledges to pay electricity rates that will cover costs for its data centers, seeking to quell consumer anxiety over power prices. And, Klarna CEO Sebastian Siemiatkowski weighs in on President Trump's call for a one-year 10% interest rate cap on credit cards. (Source: Bloomberg)...
|
|
|
13.01.26 - 15:36
|
Here′s Proof That UK′s X Ban Threat Has Nothing To Do With Protecting Children (ZeroHedge)
|
|
|
Here's Proof That UK's X Ban Threat Has Nothing To Do With Protecting Children
Authored by Steve Watson via Modernity.news,
As UK authorities ramp up their assault on free speech, a viral post shared by Elon Musk exposes the glaring hypocrisy in the government's “protect the children” narrative. Data from the The National Society for the Prevention of Cruelty to Children (NSPCC) and police forces reveals Snapchat as the epicenter of online child sexual grooming, dwarfing X's minimal involvement.
This comes amid Keir Starmer's escalating war on X, where community notes routinely dismantle government spin, and unfiltered truth is delivered to the masses. If safeguarding kids was the real goal, it would be the likes of Snapchat in the crosshairs, given that thousands of real world child sexual offences have originated from its use.
Instead they're going after X because, they claim, it provides the ability to make fake images of anyone in a bikini using the inbuilt Grok Ai image generato...
|
|
|
|
|
13.01.26 - 15:03
|
Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025.
Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh.
The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “...
|
|
|
13.01.26 - 14:33
|
Wiley Appoints Armughan Rafat as Chief AI and Data Services Officer (Business Wire)
|
|
|
Proven Leader to Accelerate Wiley's AI Momentum and Growth in Corporate R&D MarketsHOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the appointment of Armughan Rafat as chief AI and data services officer.
Rafat will lead Wiley's AI and data services initiatives, focusing on developing and commercializing AI-ready content and data products for AI developers and corporate R&D teams. He will report to President and CEO Matt Kissner and join the company's Executive Leadership Team.
Rafat has a proven track record as an innovator responsible for building high-margin businesses and capabilities that convert content assets into predictive data and AI services. Most recently, Rafat served as chief analytics officer at Norstella, where he drove AI-powered innovation in pharma and healthcare. Prior to that, as chief data officer at Clarivate, he led the compan...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
